CELLDEX THERAPEUTICS INC NEW's ticker is and the CUSIP is 15117B902. A total of 5 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $8,762,462 | +58.6% | 196,600 | 0.0% | 0.45% | +41.2% |
Q3 2022 | $5,526,000 | -65.5% | 196,600 | -66.9% | 0.32% | -65.6% |
Q2 2022 | $16,036,000 | +18.7% | 594,800 | +50.0% | 0.93% | +112.6% |
Q1 2022 | $13,508,000 | -11.3% | 396,600 | +0.6% | 0.44% | -20.7% |
Q4 2021 | $15,236,000 | – | 394,300 | – | 0.55% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PURA VIDA INVESTMENTS, LLC | 396,600 | $13,508,000 | 0.44% |
SIMPLEX TRADING, LLC | 95,300 | $3,245,000 | 0.00% |
GROUP ONE TRADING, L.P. | 38,200 | $1,301,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |